Attached files

file filename
8-K - 8-K - InvenSense Incd918409d8k.htm

Exhibit 99.1

INVENSENSE® ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2015 RESULTS

SAN JOSE, California, May 4, 2015 – InvenSense, Inc. (NYSE: INVN) the leading provider of intelligent sensor system on chip (SoC) for motion and sound, today announced results for its fourth quarter and fiscal year ended March 29, 2015.

Net revenue for the fourth quarter of fiscal 2015 was $99.3 million, down 14 percent from $115.9 million for the third quarter of fiscal 2015, and up 68 percent from $59.0 million for the fourth quarter of fiscal 2014.

Gross margin determined in accordance with U.S. generally accepted accounting principles (GAAP) was 43 percent for the fourth quarter of fiscal 2015, consistent with the third quarter of fiscal 2015. GAAP gross margin for fourth quarter of fiscal 2015 included stock-based compensation and related payroll taxes, and amortization of acquisition intangibles. Excluding these items, non-GAAP gross margin was 46 percent for the fourth quarter of fiscal 2015, consistent with the third quarter of fiscal 2015.

GAAP net income for the fourth quarter of fiscal 2015 was $0.4 million, or zero cents per diluted share. By comparison, GAAP net income was $10.2 million, or 11 cents per diluted share for the third quarter of fiscal 2015. GAAP net income for the fourth quarter of fiscal 2015 included stock-based compensation and related payroll taxes, accreting interest expense on convertible notes, amortization of acquisition intangibles, business acquisition costs, certain legal expenses and the income tax effect of non-GAAP adjustments. Excluding these items, non-GAAP net income for the fourth quarter of fiscal 2015 was $11.4 million, or 12 cents per diluted share, compared with $19.3 million, or 21 cents per diluted share, for the third quarter of fiscal 2015.

The reconciliation between GAAP and non-GAAP financial results for all referenced periods is provided in a table immediately following the Unaudited GAAP Condensed Consolidated Statements of Operations below.

Fiscal Year 2015 Results

Net revenue for the fiscal year 2015 was $372.0 million, up $119.5 million, or 47% from $252.5 million for the fiscal year 2014.

GAAP net loss for the fiscal year 2015 was $1.1 million, compared with net income of $6.1 million for the fiscal year 2014. On a non-GAAP basis, net income for the fiscal year 2015 was $42.7 million, or $0.46 per diluted share. This compares with non-GAAP net income of $52.3 million, or $0.58 per diluted share for the fiscal year 2014.

GAAP diluted net loss per share for the fiscal year 2015 was one cent, compared with diluted net income per share of seven cents for the fiscal year 2014.

Management Qualitative Comments

“Fiscal 2015 was a significant year for InvenSense,” said Behrooz Abdi, president and CEO. “We achieved the highest revenue in company history, driven by strong market share gains and several high-volume customer wins. We also brought to market a record number of new products across our motion sensor, software and microphone portfolio intended to open up incremental revenue growth opportunities over the coming quarters. Our success in mobile in fiscal 2015 laid important groundwork for our continued achievement in the coming year, while the advancement of our platform strategy provides us with multiple entry points into verticals beyond mobile where our technology can provide significant value in the years to come.”

Fourth Quarter and Fiscal Year 2015 Earnings Conference Call

A conference call will be held today at 1:30 p.m. Pacific Time to discuss the quarter and fiscal year’s results and management’s current business outlook. To listen to the conference call, please dial (866) 202-3048 ten minutes prior to the start of the call, using the passcode 76139380. International callers, please dial (617) 213-8843. A taped replay will be made available approximately two hours after the conclusion of the call and will remain available for two days. To access the replay, please dial (888) 286-8010 and enter passcode 99966713. International callers please dial (617) 801-6888. The conference call will be available via a live webcast on the investor relations section of InvenSense`s web site at www.invensense.com/ir. An archived webcast replay will be available on the web site for three months.


Note Regarding Use of Non-GAAP Financial Measures

As discussed above, in addition to the company’s condensed consolidated financial statements, which are presented according to GAAP, the company provides certain non-GAAP financial information that excludes, stock-based compensation expense and related payroll taxes, certain legal expenses, business acquisition costs, amortization of fair value write-up of acquired inventory, amortization of acquisition intangibles, accreting interest expense on convertible notes, other adjustments and the income tax effect of non-GAAP adjustments. The company uses these non-GAAP measures in its own financial and operational decision-making processes. Further, the company believes that these non-GAAP measures offer an important analytical tool to help investors understand the company’s core operating results and trends and facilitate comparability with the operating results of other companies that provide similar non-GAAP measures. These non-GAAP measures have certain limitations as analytical tools and are not meant to be considered in isolation or as a substitute for GAAP financial information. For example, stock-based compensation is an important component of the company’s compensation mix and will continue to result in significant expenses in the company’s GAAP results for the foreseeable future, but it is not reflected in our non-GAAP measures. Also, other companies, including companies in the company’s industry, may calculate non-GAAP financial measures differently, limiting their usefulness as comparative measures.

Forward-Looking Statements

Statements in this press release that are not historical are “forward-looking statements” as the term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally written in the future tense and/or preceded by words such as “will,” “expects,” “anticipates,” or other words that imply or predict a future state. Forward-looking statements include any projection of revenue, gross margin, expense, earnings, stockholder return or other financial items discussed in this press release, including the strength of our competitive positioning, growth opportunities and our ability to capitalize on them, and our ability to enter verticals beyond mobile. Investors are cautioned that all forward-looking statements in this release involve risks and uncertainty that can cause actual results to differ from those currently anticipated, due to a number of factors, including without limitation, intense competition in our industry; our achievement of design wins; our dependence on a limited number of customers for a substantial portion of our revenues; the continued adoption of motion tracking and motion sensing as an interface in consumer electronics products; decreases in average selling prices for our products; our lack of long-term supply contracts and dependence on limited sources of supply; consumer acceptance of our customers’ products that incorporate our solutions and our ability to continue to develop and introduce new and enhanced products on a timely basis; as well as changes in economic conditions in our markets and other risk factors discussed in InvenSense’s Annual Report on Form 10-K for the year ended March 30, 2014, subsequent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K, and other documents filed by us with the Securities and Exchange Commission (SEC) from time to time. Copies of InvenSense’s SEC filings are posted on the company’s website and are available from the company without charge. Forward-looking statements are made as of the date of this release, and, except as required by law, the company does not undertake an obligation to update its forward-looking statements to reflect future events or circumstances.


About InvenSense

InvenSense, Inc. (NYSE: INVN) is the world’s leading provider of intelligent sensor system on chip (SoC) for Motion and Sound in consumer electronic devices. The company’s patented InvenSense Fabrication Platform and MotionFusion® technology address the emerging needs of many mass-market consumer applications via improved performance, accuracy, and intuitive motion-, gesture- and sound-based interfaces. InvenSense technology can be found in Mobile, Wearables, Smart Home, Industrial, and Automotive products. InvenSense is headquartered in San Jose, California and has offices in Boston, China, Taiwan, Korea, Japan, France, Canada, Slovakia and Italy. More information can be found at www.invensense.com or follow us on Twitter at @InvenSense.

©2015 InvenSense, Inc. All rights reserved. InvenSense, Sensing Everything, FireFly, MotionTracking, MotionProcessing, MotionProcessor, MotionFusion, MotionApps, DMP, AAR, and the InvenSense logo are trademarks of InvenSense, Inc. Other company and product names may be trademarks of the respective companies with which they are associated.

For Investor Inquiries, Contact:

Leslie Green

Green Communications Consulting, LLC

650.312.9060

ir@invensense.com

For Press Inquiries, Contact:

David Almoslino

Senior Director

Marketing and Communications

InvenSense, Inc.

408.501.2278

pr@invensense.com


INVENSENSE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended     Fiscal Years Ended  
     March 29,
2015
    December 28,
2014
    March 30,
2014
    March 29,
2015
    March 30,
2014
 
            

Net revenue

   $ 99,279      $ 115,864      $ 58,998      $ 372,019      $ 252,533   

Costs of revenue

     56,333        65,468        31,675        216,160        127,724   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  42,946      50,396      27,323      155,859      124,809   

Operating expenses:

Research and development

  25,231      24,391      15,985      90,623      48,431   

Selling, general and administrative

  15,325      15,551      15,102      59,386      51,344   

Litigation settlement

  —        —        500      —        15,000   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

  40,556      39,942      31,587      150,009      114,775   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from operations

  2,390      10,454      (4,264   5,850      10,034   

Interest (expense)

  (2,659   (2,690   (4,294   (10,553   (4,012

Other income (expense), net

  269      (281   1,842      1,368      167   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

  —        7,483      (6,716   (3,335   6,189   

Income tax provision (benefit)

  (399   (2,738   (1,084   (2,255   70   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

$ 399    $ 10,221    $ (5,632 $ (1,080 $ 6,119   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share:

Basic

$ 0.00    $ 0.11    $ (0.06 $ (0.01 $ 0.07   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

$ 0.00    $ 0.11    $ (0.06 $ (0.01 $ 0.07   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding used in computing net income (loss) per share:

Basic

  90,359      89,779      87,691      89,359      86,520   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

  92,619      92,336      87,691      89,359      89,928   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


INVENSENSE, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS

(In thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended     Fiscal Years Ended  
     March, 29,
2015
    December, 28,
2014
    March, 30,
2014
    March 29,
2015
    March 30,
2014
 

GAAP net income (loss)

   $ 399      $ 10,221      $ (5,632   $ (1,080   $ 6,119   

Adjustments:

          

Stock based compensation expense

     7,954        8,309        5,128        31,140        16,024   

Convertible note accretion interest expense

     1,926        1,886        1,786        7,484        2,854   

Amortization of acquisition-related intangible assets

     2,034        2,034        1,244        6,940        2,073   

Amortization of fair value write-up of acquired inventory

     —          —          552        146        1,835   

Business acquisition costs

     119        1,160        414        3,388        2,417   

Patent litigation legal expense, net

     905        1,187        3,730        3,304        13,133   

Gain on equity investment

     —          —          —          (890  

Write-off of in-process research and development

     —          —          —          770     

Litigation settlement cost

     —          —          500        —          15,000   

Other

     —          —          274        68        274   

Income tax – discrete cumulative benefit

     —          —          —          —          622   

Income tax effect of pretax non-GAAP adjustments

     (1,896     (5,519     (1,994     (8,607     (8,093
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP net income

$ 11,441    $ 19,278    $ 6,002    $ 42,663    $ 52,258   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

GAAP net income (loss) per share of common stock, diluted

$ 0.00    $ 0.11    $ (0.06 $ (0.01 $ 0.07   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP net income per share of common stock, diluted

$ 0.12    $ 0.21    $ 0.07    $ 0.46    $ 0.58   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

GAAP Gross profit

$ 42,946    $ 50,396    $ 27,323    $ 155,859    $ 124,809   

Adjustments:

Stock based compensation expense

  621      591      452      2,431      1,296   

Amortization of acquisition-related intangible assets

  1,978      1,978      1,188      6,716      1,980   

Amortization of fair value write-up of acquired inventory

  —        —        552      146      1,835   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross profit

$ 45,545    $ 52,965    $ 29,515    $ 165,152    $ 129,920   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

GAAP Operating Expense

$ 40,556    $ 39,942    $ 31,587    $ 150,009    $ 114,775   

Adjustments:

Stock based compensation expense

  7,333      7,718      4,676      28,709      14,728   

Amortization of acquisition-related intangible assets

  56      56      56      224      93   

Business acquisition costs

  119      1,160      414      3,388      2,417   

Patent litigation legal expense, net

  905      1,187      3,730      3,304      13,133   

Write-off of in-process research and development

  —        —        —        770   

Litigation settlement cost

  —        —        500      —        15,000   

Other

  —        —        274      68      274   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Expense

$ 32,143    $ 29,821    $ 21,937    $ 113,546    $ 69,130   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


INVENSENSE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)

(Unaudited)

 

     March 29,
2015
    March 30,
2014
 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 85,637      $ 26,025   

Short-term investments

     129,919        91,307   

Accounts receivable

     44,522        39,009   

Inventories

     75,105        73,032   

Prepaid expenses and other current assets

     14,950        19,587   
  

 

 

   

 

 

 

Total current assets

  350,133      248,960   

Property and equipment, net

  41,849      25,239   

Intangible assets, net

  45,508      35,360   

Goodwill

  139,175      50,952   

Long-term investments

  —        128,755   

Other assets

  9,226      5,469   
  

 

 

   

 

 

 

Total assets

$ 585,891    $ 494,735   
  

 

 

   

 

 

 

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$ 23,130    $ 18,964   

Accrued liabilities

  31,991      14,985   
  

 

 

   

 

 

 

Total current liabilities

  55,121      33,949   

Long-term debt

  143,017      135,583   

Other long-term liabilities

  28,252      11,375   
  

 

 

   

 

 

 

Total liabilities

  226,390      180,907   
  

 

 

   

 

 

 

Stockholders’ equity:

Preferred stock:

Preferred stock, $0.001 par value — 20,000 shares authorized, no shares issued and outstanding and outstanding at March 29, 2015 and March 30, 2014

  —        —     

Common stock:

Common stock, $0.001 par value — 750,000 shares authorized, 90,894 shares issued and outstanding at March 29, 2015, 88,332 shares issued and outstanding at March 30, 2014

  262,677      215,958   

Accumulated other comprehensive (loss)

  (4   (38

Retained earnings

  96,828      97,908   
  

 

 

   

 

 

 

Total stockholders’ equity

  359,501      313,828   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

$ 585,891    $ 494,735   
  

 

 

   

 

 

 


INVENSENSE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

     Three Months Ended     Fiscal Years Ended  
     March 29,
2015
    December 28,
2014
    March 30,
2014
    March 29,
2015
    March 30,
2014
 

Cash flows from operating activities:

          

Net income (loss)

   $ 399      $ 10,221      $ (5,632   $ (1,080   $ 6,119   

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

          

Depreciation

     2,847        3,047        1,559        10,203        4,492   

Amortization of intangible assets

     2,074        2,034        1,244        7,003        2,073   

Write-off of in-process research and development

     —          —          —          770        —     

Loss on disposal of property and equipment

     95        131        —          552        —     

Gain on equity investment

     —          —          —          (890     —     

Stock-based compensation expense

     7,566        8,300        5,128        30,504        16,024   

Deferred income tax assets

     (272     (5,237     (2,338     (5,484     (2,337

Tax effect of employee benefit plans

     —          42        1,608        42        4,839   

Excess tax benefit from stock-based compensation

     —          (42     (1,608     (42     (4,839

Non cash interest expense

     1,926        1,907        1,785        7,505        2,854   

Changes in operating assets and liabilities:

          

Accounts receivable

     29,413        (7,010     (4,230     (4,895     (8,911

Inventories

     (7,304     7,210        (14,521     (2,072     (44,164

Prepaid expenses and other current assets

     7,778        946        (152     8,778        (2,699

Other assets

     25        940        387        (135     (1,013

Accounts payable

     2,494        (4,771     6,815        3,122        4,474   

Accrued liabilities

     4,737        94        (13,136     12,961        11,790   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) operating activities

  51,778      17,812      (23,091   66,842      (11,298
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

Purchase of property and equipment

  (2,031   (7,665   (2,525   (27,315   (17,207

Sale and maturities of available-for-sale investments

  33,252      14,200      23,088      145,974      86,233   

Purchase of available-for-sale investments

  (55,845   —        (17,843   (55,845   (206,949

Purchase of intangible assets

  (2,120   —        —        (2,120   —     

Acquisitions, net of cash acquired

  —        120      —        (71,326   (99,324
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

  (26,744   6,655      2,720      (10,632   (237,247
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

Proceeds from exercise of common stock

  2,602      2,124      4,152      10,425      13,115   

Proceeds from debt issuances, net of issuance costs

  —        —        (491   —        169,259   

Proceeds from sale of warrants

  —        —        —        —        25,643   

Payments of long-term debt and capital lease obligations

  —        —        —        (9   (11

Payments for purchase of convertible notes hedge

  —        —        —        (39,118

Payments contingent consideration

  (7,056   —        —        (7,056   —     

Excess tax benefit from stock-based compensation

  —        42      1,608      42      4,839   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

  (4,454   2,166      5,269      3,402      173,727   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

  20,580      26,633      (15,102   59,612      (74,818

Cash and cash equivalents:

Beginning of period

  65,057      38,424      41,127      26,025      100,843   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

End of period

$ 85,637    $ 65,057    $ 26,025    $ 85,637    $ 26,025